Heart Surgery

Latest Issue of OR Manager
May 2024
Home Surgery/Specialties > Heart Surgery

The Joint Commission revises CCC Certification program

Editor's Note The Joint Commission, on February 15, announced that its Comprehensive Cardiac Center (CCC) Certification program has been fully revised to:   reduce redundancy  clarify requirements  closely align requirements with other Joint Commission cardiac certification programs.  The revised requirements will be effective July 1. 

Read More

By: Judy Mathias
February 16, 2023
Share

Surgical resident diversity remains largely stagnant

Editor's Note This study led by researchers at Cedars Sinai Medical Center, Los Angeles, finds that underrepresentation of minorities persists across all surgical specialties, while representation of females improves. The cross-sectional study examined race, ethnicity and attrition data of 112,205 surgical residents across 18 years (2001-2018) in 10 surgical specialties.…

Read More

By: Lindsay Botts
February 9, 2023
Share

FDA: Addition to Class I recall of LivaNova LifeSPARC System Controller

Editor's Note The Food and Drug Administration (FDA) on January 27 posted an addition to the Class I recall by LivaNova (TandemLife) of its LifeSPARC System Controller. The addition to the recall provides information about a software update now available to address the previous software malfunction and recall. The System…

Read More

By: Judy Mathias
January 30, 2023
Share

FDA: Class I recall of Datascope/Getinge Cardiosave Hybrid, Rescue IABPs

Editor's Note The Food and Drug Administration (FDA) on January 25 identified the recall by Datascope/Gettinge of its Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps (IABPs) as Class I, the most serious. The recall was initiated because of the risk that blood may enter the pump through a damaged balloon…

Read More

By: Judy Mathias
January 26, 2023
Share

Sponsored Message

FDA: Class I recall of Arrow AutoCAT2, AC3 IABPs

Editor's Note The Food and Drug Administration (FDA), on December 20, identified the recall by Arrow International, LLC, subsidiary of Teleflex, Inc, of its Arrow AutoCAT 2 and AC3 intra-aortic balloon pumps (IABPs) as Class I, the most serious. IABPs are used in patients having cardiac and non-cardiac surgery, and…

Read More

By: Judy Mathias
January 3, 2023
Share

Study: Better OR ventilation linked to lower SSI rates

Editor's Note This Swiss study finds that better OR ventilation properties, as assessed with a new ventilation index, are associated with lower rates of surgical site infections (SSIs) in orthopedic, spine, and cardiac procedures. Researchers calculated a ventilation index with higher values reflecting less turbulent air displacement instead of comparing…

Read More

By: Judy Mathias
October 10, 2022
Share

Sponsored Message

FDA: Class I recall of LivaNova’s LifeSPARC System

Editor's Note The Food and Drug Administration (FDA) on September 30 identified the recall by LivaNova (TandemLife) of its LifeSPARC System, Model LS-1000, as Class I, the most serious. The recall was initiated because of the risk of unintentional extended pump stop during Controller Critical Failure mode, caused by a…

Read More

By: Judy Mathias
October 3, 2022
Share

FDA: Class I recall of Medtronic’s HeartWare HVAD system batteries

Editor's Note The Food and Drug Administration on August 25 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) system batteries as Class I, the most serious. Medtronic is recalling the batteries because they may experience electrical faults that cause them to unexpectedly fail. A similar recall…

Read More

By: Judy Mathias
August 29, 2022
Share

FDA: Class I recall of Medtronic’s HVAD batteries

Editor's Note The Food and Drug Administration (FDA), on June 23, identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) batteries as Class I, the most serious. The recall for a single lot (Model Number:1650DE) of HVAD batteries was initiated because of welding defects that allow separation…

Read More

By: Judy Mathias
June 27, 2022
Share

FDA: Class I recall of Medtronic HVAD Pump Implant Kit

Editor's Note The Food and Drug Administration (FDA) on June 8 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit as Class I, the most serious. The HVAD System is used as a bridge to cardiac transplants. The Kit was recalled because of a…

Read More

By: Judy Mathias
June 9, 2022
Share
Live chat by BoldChat